Journal article Closed Access

Meningococcal vaccine evolution

Bona, Gianni; Guidi, Carla

Neisseria meningitidis is a leading cause of bacterial sepsis and meningitis worldwide. Although polysaccharide and glycoconjugate vaccines have been developed for serogroups A, C, Y and W-135, currently there are no broadly effective vaccines available for the prevention of meningococcal B disease. A general overview of the burden of the disease and the strains prevalence in the world with the focus in particular on the Italian situation is provided in this article, together with the vaccinations developed and under evaluation.

Files
Closed Access

Files are not publicly accessible.

0
0
views
downloads
Views 0
Downloads 0
Data volume 0 Bytes
Unique views 0
Unique downloads 0
Publication date:
June 13, 2016
DOI:
10.7175/cmi.v6i2.627

INFN Open Access Repository DOI Badge

DOI 

10.7175/cmi.v6i2.627

Markdown 

[![DOI](https://www.openaccessrepository.it/badge/DOI/10.7175/cmi.v6i2.627.svg)](https://doi.org/10.7175/cmi.v6i2.627)

reStructedText 

.. image:: https://www.openaccessrepository.it/badge/DOI/10.7175/cmi.v6i2.627.svg
   :target: https://doi.org/10.7175/cmi.v6i2.627

HTML 

<a href="https://doi.org/10.7175/cmi.v6i2.627"><img src="https://www.openaccessrepository.it/badge/DOI/10.7175/cmi.v6i2.627.svg" alt="DOI"></a>

Image URL 

https://www.openaccessrepository.it/badge/DOI/10.7175/cmi.v6i2.627.svg

Target URL 

https://doi.org/10.7175/cmi.v6i2.627

Keyword(s):
Business, Management and Accounting (miscellaneous) Medicine (miscellaneous)
Communities:
License (for files):
Creative Commons Attribution-NonCommercial 4.0

Share

Cite as

Export